Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics Inc. on the transaction. Denali Therapeutics (Nasdaq: DNLI) announced that it entered into a securities purchase agreement with...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here